SI1804804T1 - 3-?á4-(DIBENZO?áb,f?å?á1,4?åOXAZEPIN-11-YL)-PIPERAZIN-1-YL?å-2,2-DIMETHYL PROPANOIC ACID FOR USE IN THE TREATMENT OF SLEEP DISORDERS - Google Patents

3-?á4-(DIBENZO?áb,f?å?á1,4?åOXAZEPIN-11-YL)-PIPERAZIN-1-YL?å-2,2-DIMETHYL PROPANOIC ACID FOR USE IN THE TREATMENT OF SLEEP DISORDERS

Info

Publication number
SI1804804T1
SI1804804T1 SI200531483T SI200531483T SI1804804T1 SI 1804804 T1 SI1804804 T1 SI 1804804T1 SI 200531483 T SI200531483 T SI 200531483T SI 200531483 T SI200531483 T SI 200531483T SI 1804804 T1 SI1804804 T1 SI 1804804T1
Authority
SI
Slovenia
Prior art keywords
åoxazepin
dibenzo
piperazin
treatment
propanoic acid
Prior art date
Application number
SI200531483T
Other languages
Slovenian (sl)
Inventor
Dale M Edgar
David G Hangauer
Kazumi Shiosaki
Michael Solomon
James F White
Original Assignee
Hypnion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hypnion Inc filed Critical Hypnion Inc
Priority claimed from EP05801120A external-priority patent/EP1804804B1/en
Publication of SI1804804T1 publication Critical patent/SI1804804T1/en

Links

SI200531483T 2004-09-21 2005-09-21 3-?á4-(DIBENZO?áb,f?å?á1,4?åOXAZEPIN-11-YL)-PIPERAZIN-1-YL?å-2,2-DIMETHYL PROPANOIC ACID FOR USE IN THE TREATMENT OF SLEEP DISORDERS SI1804804T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61184904P 2004-09-21 2004-09-21
US67319805P 2005-04-19 2005-04-19
EP05801120A EP1804804B1 (en) 2004-09-21 2005-09-21 3-[4-(DIBENZO[b,f][1,4]OXAZEPIN-11-YL)-PIPERAZIN-1-YL]-2,2-DIMETHYL PROPANOIC ACID FOR USE IN THE TREATMENT OF SLEEP DISORDERS
PCT/US2005/034015 WO2006034414A2 (en) 2004-09-21 2005-09-21 Loxapine analogs and methods of use thereof

Publications (1)

Publication Number Publication Date
SI1804804T1 true SI1804804T1 (en) 2012-04-30

Family

ID=38866598

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531483T SI1804804T1 (en) 2004-09-21 2005-09-21 3-?á4-(DIBENZO?áb,f?å?á1,4?åOXAZEPIN-11-YL)-PIPERAZIN-1-YL?å-2,2-DIMETHYL PROPANOIC ACID FOR USE IN THE TREATMENT OF SLEEP DISORDERS

Country Status (4)

Country Link
CN (1) CN101060847B (en)
SI (1) SI1804804T1 (en)
UA (1) UA86265C2 (en)
ZA (1) ZA200702334B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000506528A (en) * 1996-03-11 2000-05-30 イーライ・リリー・アンド・カンパニー How to treat insomnia
WO2004056182A1 (en) * 2002-12-20 2004-07-08 Basf Aktiengesellschaft Pesticidal dibenzo(hetero)azepine derivatives
CN100402036C (en) * 2004-04-26 2008-07-16 袁重华 Coating agent for treating insomnia and its usage

Also Published As

Publication number Publication date
CN101060847A (en) 2007-10-24
UA86265C2 (en) 2009-04-10
CN101060847B (en) 2010-05-05
ZA200702334B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
PL1804804T3 (en) 3-[4-(DIBENZO[b,f][1,4]OXAZEPIN-11-YL)-PIPERAZIN-1-YL]-2,2-DIMETHYL PROPANOIC ACID FOR USE IN THE TREATMENT OF SLEEP DISORDERS
HK1079400A1 (en) Compounds for the treatment of metabolic disorders
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
IL209842A0 (en) Compounds for the treatment of metabolic disorders
PL1611091T3 (en) Substituted phenylalkanoic acid derivatives and their use for respiratory disease treatment
ZA200803440B (en) Compounds for the treatment of metabolic disorders
IL187168A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
IL173909A0 (en) Use of modified cyclosporins for the treatment of hcv disorders
IL180680A0 (en) Piperazine derivatives useful for the treatment of gastrointestinal disorders
ZA200606834B (en) 1-Aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with Alzheimer's disease
PT2982372T (en) Glutamate modulating agents in the treatment of mental disorders
ME01219B (en) Alfa-aminoamide derivatives useful in the treatment of addictive disorders
HK1100481A1 (en) Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient
AU2003286728A8 (en) Compounds for the treatment of metabolic disorders
EP1876900A4 (en) Phosphoinositide modulation for the treatment of alzheimer's disease
AU2003299715A8 (en) Compounds for the normalization of the sleep/wake cycle
EP1581206A4 (en) Treatment of inflammatory disorders with 2,3-benzodiazepines
ZA200505989B (en) Use the steroids to treat ocular disorders
HK1074402A1 (en) Use of amide derivative of ge 2270 factor a3 for the treatment of acne
IL150290A0 (en) The use of mirtazapine for the treatment of sleep disorders
SI1804804T1 (en) 3-?á4-(DIBENZO?áb,f?å?á1,4?åOXAZEPIN-11-YL)-PIPERAZIN-1-YL?å-2,2-DIMETHYL PROPANOIC ACID FOR USE IN THE TREATMENT OF SLEEP DISORDERS
TWI318115B (en) Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
EP1869004A4 (en) Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use
HRP20041160A2 (en) Novel combination for the treatment of airway disorders
TWI340643B (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders